EchoSolv AS vs Imbio RV/LV Software
AI Verdict
Choose EchoSolv AS if…
Choose EchoSolv AS if your primary goal is to efficiently and accurately identify patients at high risk for severe aortic stenosis using AI-powered analysis of echocardiogram measurements. This tool is ideal for providing rapid clinical decision support and prioritizing studies for closer review within existing cardiology workflows, without requiring EMR integration.
View EchoSolv AS →Choose Imbio RV/LV Software if…
Choose Imbio RV/LV Software if you need automated and objective measurement of right and left ventricular diameters and the RV/LV ratio from CTPA scans. This tool is best suited for aiding in the risk stratification of patients with pulmonary conditions, such as pulmonary embolism, by providing consistent, AI-driven assessment of ventricular strain directly integrated into radiology reading environments.
View Imbio RV/LV Software →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoSolv AS | Imbio RV/LV Software |
|---|---|---|
| Deployment | Cloud-based | Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27] |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoSolv ASEchoSolv AS boasts ultra-fast risk detection in under 3 seconds, which is a significant advantage for immediate clinical decision support [JSON, cite: 35]. Both tools are designed to fit existing workflows and integrate with PACS, but EchoSolv AS explicitly states no EMR integration is required, potentially simplifying initial deployment [JSON, cite: 3, 5, 18].
Clinical Value
EchoSolv ASEchoSolv AS demonstrates superior clinical value by outperforming traditional human diagnosis, identifying 15% more severe AS cases and restoring gender equity in diagnosis. It has shown near-perfect accuracy with an AUC of 0.986 in detecting severe AS. While Imbio RV/LV Software is accurate and improves radiologist agreement, EchoSolv AS's impact on identifying missed diagnoses and addressing bias is particularly compelling.
Pricing & Value
TieBoth tools operate on a subscription-based model. Imbio RV/LV Software provides more detail, indicating pricing is based on the number of analyses and installations [JSON, cite: 23]. EchoSolv AS highlights its alignment with existing US reimbursement codes and a clear pathway to a dedicated CPT code, which adds a strong financial value proposition for adopting institutions. Without specific pricing figures, a definitive winner on 'value for money' cannot be determined.
Enterprise Readiness
Imbio RV/LV SoftwareImbio RV/LV Software offers more diverse deployment options, including cloud-based, on-premise, and integration with a wider array of partner platforms such as Nuance, Aidoc, and Siemens Syngo.via [JSON, cite: 2]. This extensive compatibility and flexibility make it highly adaptable to various enterprise IT infrastructures and existing vendor relationships. While EchoSolv AS also has integration partnerships, Tool B's listed options are more comprehensive.
Innovation
EchoSolv ASEchoSolv AS employs a 'measurement-based AI' that analyzes numerical measurements rather than images and specifically avoids LVOT measurements, inferring severe AS from peripheral signs [JSON, cite: 3, 5, 8, 9, 18, 21]. This distinct methodological approach for a complex diagnosis, developed using one of the world's largest echocardiographic datasets, appears more novel than Imbio RV/LV Software's automated image measurement approach.
Support & Docs
Imbio RV/LV SoftwareImbio RV/LV Software clearly outlines its support structure, offering 24/7/365 global support via phone, email, and online case submission. It also explicitly states that user manuals and other product documentation are available upon request or on their support page. EchoSolv AS mentions 'Feedback & Support' and a user manual, but lacks the detailed, round-the-clock global support commitment of Tool B.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoSolv AS | Imbio RV/LV Software |
|---|---|---|
| Tool Name | EchoSolv AS | Imbio RV/LV Software |
| Company | Echo IQ | Imbio |
| Primary Clinical Focus | Identifies patients at risk for severe aortic stenosis. | Aids in risk stratification for pulmonary conditions (e.g., pulmonary embolism) by measuring RV/LV ratio. |
| Input Data Type | Echocardiograms (analyzes numerical measurements, not images) | CTPA scans |
| Key Output | Severe AS probability and guideline check from measurements. | Automated measurement of right and left ventricular diameters, calculation and reporting of RV/LV ratio, annotated images, summary PDF reports. |
| Integration | Designed to fit existing workflows (no EMR integration required, integrates with PACS). | Integration with standard reading environments (PACS), DICOM compliant input and output. |
Videos
Demos, reviews, and walkthroughs featuring EchoSolv AS and Imbio RV/LV Software.